share_log

4: Statement of changes in beneficial ownership of securities-Officer DOW GEOFFREY S

4: Statement of changes in beneficial ownership of securities-Officer DOW GEOFFREY S

4:持股变动声明-高管 DOW GEOFFREY S
美股SEC公告 ·  05/21 20:20
Moomoo AI 已提取核心信息
Geoffrey S. Dow, President and CEO of 60 Degrees Pharmaceuticals, completed the purchase of 85,000 shares of the company's common stock through a series of transactions. The acquisitions occurred between April 12, 2024, and May 16, 2024, with prices ranging from $0.223 to $0.2668 per share. Following these transactions, Dow's direct holdings in the company increased to 762,625 shares. The transactions are reported as exercises or conversions of derivative securities, indicating a potential increase in the executive's stake in the company.
Geoffrey S. Dow, President and CEO of 60 Degrees Pharmaceuticals, completed the purchase of 85,000 shares of the company's common stock through a series of transactions. The acquisitions occurred between April 12, 2024, and May 16, 2024, with prices ranging from $0.223 to $0.2668 per share. Following these transactions, Dow's direct holdings in the company increased to 762,625 shares. The transactions are reported as exercises or conversions of derivative securities, indicating a potential increase in the executive's stake in the company.
60 Degrees Pharmicals总裁兼首席执行官杰弗里·陶通过一系列交易完成了对公司85,000股普通股的收购。这些收购发生在2024年4月12日至2024年5月16日之间,价格从每股0.223美元到0.2668美元不等。这些交易之后,陶氏在该公司的直接持股量增加到762,625股。这些交易被报告为衍生证券的行使或转换,这表明该高管在公司的股份可能增加。
60 Degrees Pharmicals总裁兼首席执行官杰弗里·陶通过一系列交易完成了对公司85,000股普通股的收购。这些收购发生在2024年4月12日至2024年5月16日之间,价格从每股0.223美元到0.2668美元不等。这些交易之后,陶氏在该公司的直接持股量增加到762,625股。这些交易被报告为衍生证券的行使或转换,这表明该高管在公司的股份可能增加。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息